KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Novavax (NVAX) Interest & Investment Income (2016 - 2021)

Novavax has reported Interest & Investment Income over the past 12 years, most recently at $303000.0 for Q4 2021.

  • Quarterly results put Interest & Investment Income at $303000.0 for Q4 2021, up 113.38% from a year ago — trailing twelve months through Dec 2021 was $1.4 million (up 34.38% YoY), and the annual figure for FY2021 was $1.4 million, up 34.52%.
  • Interest & Investment Income for Q4 2021 was $303000.0 at Novavax, down from $330000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for NVAX hit a ceiling of $807000.0 in Q2 2018 and a floor of $140000.0 in Q3 2020.
  • Median Interest & Investment Income over the past 5 years was $419000.0 (2017), compared with a mean of $425550.0.
  • Biggest five-year swings in Interest & Investment Income: crashed 59.06% in 2020 and later skyrocketed 135.71% in 2021.
  • Novavax's Interest & Investment Income stood at $418000.0 in 2017, then skyrocketed by 39.71% to $584000.0 in 2018, then crashed by 52.74% to $276000.0 in 2019, then crashed by 48.55% to $142000.0 in 2020, then skyrocketed by 113.38% to $303000.0 in 2021.
  • The last three reported values for Interest & Investment Income were $303000.0 (Q4 2021), $330000.0 (Q3 2021), and $369000.0 (Q2 2021) per Business Quant data.